BORRIELLO, Giovanna
 Distribuzione geografica
Continente #
AS - Asia 1.764
NA - Nord America 889
EU - Europa 879
SA - Sud America 219
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.780
Nazione #
US - Stati Uniti d'America 824
SG - Singapore 810
RU - Federazione Russa 524
CN - Cina 451
VN - Vietnam 221
BR - Brasile 183
IT - Italia 120
HK - Hong Kong 105
FR - Francia 53
KR - Corea 43
DE - Germania 38
CA - Canada 32
GB - Regno Unito 31
JP - Giappone 27
IN - India 24
NL - Olanda 24
PL - Polonia 21
MX - Messico 18
BD - Bangladesh 16
AR - Argentina 15
FI - Finlandia 14
ID - Indonesia 14
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
PK - Pakistan 9
AT - Austria 8
ES - Italia 8
TH - Thailandia 8
SE - Svezia 6
TR - Turchia 6
CL - Cile 5
CO - Colombia 5
PH - Filippine 5
SA - Arabia Saudita 5
EC - Ecuador 4
IE - Irlanda 4
JM - Giamaica 4
LT - Lituania 4
SN - Senegal 4
AZ - Azerbaigian 3
MY - Malesia 3
PA - Panama 3
PY - Paraguay 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
IQ - Iraq 2
MA - Marocco 2
PE - Perù 2
TW - Taiwan 2
UZ - Uzbekistan 2
AO - Angola 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GD - Grenada 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 3.780
Città #
Singapore 434
Hefei 243
San Jose 205
Moscow 136
Santa Clara 124
Hong Kong 101
Ashburn 74
Beijing 69
Ho Chi Minh City 68
Hanoi 52
Seoul 40
Los Angeles 33
Lauterbourg 32
Tokyo 24
New York 21
Council Bluffs 19
The Dalles 19
Naples 18
São Paulo 17
Buffalo 15
Redondo Beach 15
Warsaw 15
Munich 14
Rome 12
Brno 11
Orem 11
Boston 10
Dallas 10
Houston 10
Da Nang 9
Milan 9
Phoenix 9
Amsterdam 8
Brooklyn 8
Falkenstein 8
Frankfurt am Main 8
Helsinki 8
Montreal 8
Seattle 8
Toronto 8
London 7
Rio de Janeiro 7
Chennai 6
Denver 6
Haiphong 6
Johannesburg 6
Stockholm 6
Ankara 5
Belo Horizonte 5
Biên Hòa 5
Boardman 5
Poplar 5
Querétaro 5
San Francisco 5
Thái Nguyên 5
Wroclaw 5
Brasília 4
Campinas 4
Chicago 4
Dakar 4
Jakarta 4
Lewisham 4
Mexico City 4
Nuremberg 4
Padova 4
Porto Alegre 4
Ribeirão Preto 4
Vienna 4
Arcore 3
Bahadurgarh 3
Baku 3
Bologna 3
Curitiba 3
Dublin 3
Guangzhou 3
Guayaquil 3
Hải Dương 3
Jeddah 3
Kingston 3
Lahore 3
Lappeenranta 3
Manchester 3
Miami 3
Mumbai 3
Nha Trang 3
Panama City 3
Quận Bình Thạnh 3
Rochdale 3
Roubaix 3
Sorocaba 3
Turku 3
Verona 3
Amiens 2
Atlanta 2
Basildon 2
Betim 2
Bexley 2
Bắc Ninh 2
Can Tho 2
Canoas 2
Totale 2.168
Nome #
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 178
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod 142
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 130
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 129
Emerging oral drugs for multiple sclerosis 104
Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression 103
Treating multiple sclerosis with fingolimod or intramuscular interferon 102
Effects of an unconventional re-walking training on physical, psychological, and cognitive impairment in multiple sclerosis patients 102
fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis 101
Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis. J Neurol Sci. 2012 Dec 15;323(1-2):104-12. doi: 10.1016/j.jns.2012.08.027. Epub 2012 Sep 21 99
Reversible hyporegenerative anemia during natalizumab treatment 99
Why physical activity improves quality of life in multiple sclerosis patients: correlation between fatigue and functional parameters 97
Efficacy, safety and tolerability of dimethylfumarate during pregnancy and breastfeeding 96
Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis 93
One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis 93
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.Neurorehabil Neural Repair. 2014 Nov 14. pii: 1545968314554623 92
Natalizumab treatment in pediatric multiple sclerosis: A case report 91
Mitoxantrone treatment in multiple sclerosis: a 5-year clinical and MRI follow-up 90
Pulse monthly steroids during an elective interruption of natalizumab: A post-marketing study 90
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 90
Impact of early diagnosis on clinical characteristics of an Italian sample of people with multiple sclerosis recruited online 87
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 86
Observations during an elective interruption of natalizumab treatment: a post-marketing study 85
MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis 84
Comparable efficacy and safety of dimethyl fumarate and teriflunomide treatment in relapsing-remitting Multiple sclerosis. an Italian real-word multicenter experience 83
How an early diagnosis has impacted on clinical practice in the last years in Italy: a web-based patient-centered survey 78
Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound? 78
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 78
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis 77
Cesarean section in women with MS: a choice or a need? 76
Disability assessment in the Google Maps era: a pilot study 76
Early predictors of poor response to interferon beta therapy in a cohort of relapsing-remitting multiple sclerosis 76
Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis 75
Predicting the response status to natalizumab in relapsing-remitting multiple sclerosis 75
Home-based rehabilitation using brain training in cognitive impaired patients with multiple sclerosis 74
Relapse-associated worsening in a real-life multiple sclerosis cohort: The role of age and pyramidal phenotype 74
Cesarean section in women with MS: A choice or a need? 74
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 73
Relationship between coping strategies, clinical findings, and quality of life in the early stage of multiple sclerosis: a six-month follow-up study 72
Alopecia universalis occurring after alemtuzumab treatment for multiple sclerosis. A two-year follow-up of two patients 61
COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach 59
Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome 53
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 24
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study 20
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project 13
Totale 3.832
Categoria #
all - tutte 10.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 0 0 0 0 0 0 0 0 3 0 0 0
2023/2024127 0 0 0 1 0 0 2 0 41 5 32 46
2024/20251.222 46 80 18 4 53 92 121 93 75 85 431 124
2025/20262.480 304 319 321 287 427 90 156 129 246 130 62 9
Totale 3.832